EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A Comprehensive Review of Azelaic Acid Pharmacological Properties, Clinical Applications, and Innovative Topical Formulations

Andreea-Georgiana Petrovici, Mariachiara Spennato iD, Ioan Bîtcan iD, Francisc Péter iD, Livius Cotarcă, Anamaria Todea iD, Valentin Laurențiu Ordodi

Pharmaceuticals · 26.08.2025 · 18 (9) · 1273

DOI: 10.3390/ph18091273 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 26.08.2025. Verfasst von Andreea-Georgiana Petrovici und 6 weiteren Autor:innen. Beteiligte Einrichtung: Biocatalysis and Green Chemistry Group, Faculty Chemical Engineering, Biotechnologies and Environmental Protection, University Politehnica Timisoara,…. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Romanian Ministry of Education and Research, CCCDI-UEFISCDI, PNCDI III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Azelaic acid (AzA), a saturated dicarboxylic acid, is indicated for the treatment of acne vulgaris, rosacea, melasma, and post-inflammatory hyperpigmentation. Its antimicrobial, anti-inflammatory, and antimelanogenic properties support its use; however, its poor aqueous solubility and limited skin permeability constrain its optimal topical delivery. This review summarizes clinical evidence and advances in formulations—including conventional vehicles, polymeric/lipid nanocarriers, and deep eutectic solvent (DES) systems—to promote more effective and well-tolerated use. Across indications, 15–20% azelaic acid (AzA) formulations produced clinically meaningful improvements with mild, transient local irritation. For acne vulgaris, reductions in inflammatory and noninflammatory lesions were comparable to those of topical retinoids/adapalene, and tolerability was superior in some studies. For rosacea, the 15% gel formulation was comparable to metronidazole in reducing papules, pustules, and erythema while maintaining negligible systemic exposure. In melasma and other dyschromias, 20% cream demonstrated efficacy similar to hydroquinone, exhibiting a favorable safety profile. Advanced delivery systems, including liposomes, niosomes/ethosomes, nanostructured lipid carriers, microemulsions, nanosponges, and DES platforms, increased AzA solubilization, cutaneous deposition, and stability. This enabled dose-sparing strategies and improved adherence. Data on AzA cocrystals and ionic salts suggest additional control over release and irritation. AzA remains a versatile and well-tolerated dermatologic agent whose performance is strongly vehicle-dependent. Rational selection and engineering of carriers, particularly DES-integrated polymeric and lipid systems, can mitigate solubility and permeability limitations, enhance skin targeting, and reduce irritation in the treatment of acne and rosacea.

Schlagwörter

Stichwörter der Autor:innen

azelaic acidcontrolled releasedeep eutectic solventsformulation developmentliposomesmicroemulsionsnanocarriersnanocrystalssolid lipid nanoparticlestopical drug delivery

Autor:innen und Institutionen

  • Biocatalysis and Green Chemistry Group, Faculty Chemical Engineering, Biotechnologies and Environmental Protection, University Politehnica Timisoara, Vasile Pârvan 6, 300223 Timisoara, Romania.
  • Department of Civil, Chemical, Environmental and Materials Engineering, Alma Mater Studiorum University of Bologna, 40126 Bologna, Italy.
  • Renewable Energy Research Institute-ICER, University Politehnica Timisoara, Gavril Musicescu 138, 300501 Timisoara, Romania.
  • LC Consulting SAS, Via Martignacco 117, 33100 Udine, Italy.

ORCID-Profile: Mariachiara Spennato, Ioan Bîtcan, Francisc Péter, Anamaria Todea

Förderung

  • Romanian Ministry of Education and Research, CCCDI-UEFISCDI
  • PNCDI III

Zitieren

APA

Petrovici, A. G., Spennato, M., Bîtcan, I., Péter, F., Cotarcă, L., Todea, A., & Ordodi, V. L. (2025). A Comprehensive Review of Azelaic Acid Pharmacological Properties, Clinical Applications, and Innovative Topical Formulations. Pharmaceuticals, 18(9), 1273. https://doi.org/10.3390/ph18091273

Vancouver

Petrovici AG, Spennato M, Bîtcan I, Péter F, Cotarcă L, Todea A, et al. A Comprehensive Review of Azelaic Acid Pharmacological Properties, Clinical Applications, and Innovative Topical Formulations. Pharmaceuticals. 2025;18(9):1273. doi:10.3390/ph18091273

BibTeX
@article{Petrovici2025,
  author = {Petrovici, Andreea-Georgiana and Spennato, Mariachiara and Bîtcan, Ioan and Péter, Francisc and Cotarcă, Livius and Todea, Anamaria and Ordodi, Valentin Laurențiu},
  title = {A Comprehensive Review of Azelaic Acid Pharmacological Properties, Clinical Applications, and Innovative Topical Formulations},
  journal = {Pharmaceuticals},
  year = {2025},
  volume = {18},
  number = {9},
  pages = {1273},
  doi = {10.3390/ph18091273}
}
Kostenlos starten →